Consequences of CYP3A4 and MDR-1 polymorphisms on pharmakokinetic parameters of cyclosporin a and mycophenolic acid in pediatric renal transplant recipients.

被引:0
|
作者
Feneberg, Reinhard
Weber, Lutz T.
van Asen, Nicolas
Armstrong, Victor W.
Hoecker, Britta
Oellerich, Michael
Toenshoff, Burkhard
机构
[1] Univ Heidelberg, Dept Pediat Nephrol, Heidelberg, Germany
[2] Univ Munich, Dept Pediat Nephrol, Munich, Germany
[3] Univ Gottingen, Dept Clin Chem, D-3400 Gottingen, Germany
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
849
引用
收藏
页码:366 / 367
页数:2
相关论文
共 50 条
  • [21] Influence of MDR1 and NFKBIA polymorphisms on cyclosporin A concentrations in Chinese renal transplant recipients
    Huang Min
    Zhang Yu
    Li Jiali
    Wang Xueding
    Wang Changxi
    DRUG METABOLISM REVIEWS, 2011, 43 : 171 - 171
  • [22] Impact of CYP3A4*1B and CYP3A5*3 polymorphisms on the pharmacokinetics of cyclosporine and sirolimus in renal transplant recipients
    Zochowska, Dorota
    Wyzgal, Janusz
    Paczek, Leszek
    ANNALS OF TRANSPLANTATION, 2012, 17 (03) : 36 - 44
  • [23] MDR-1 genotypes from donors and recipients and CYP3A4 activity as indicators of dose requirements in liver transplant patients. Preliminary results
    Fanlo, A
    Bernal, M
    Serrano, T
    Barrau, E
    Valiente, C
    Garcia-Gil, A
    Sinues, B
    LIVER TRANSPLANTATION, 2003, 9 (06) : C80 - C80
  • [24] The influences of human MDR1 gene polymorphisms on pharmacokinetics of tacrolimus in renal transplant recipients.
    Uchida, S
    Takai, N
    Hashimoto, H
    Furuse, H
    Kageyama, S
    Ushiyama, T
    Suzuki, K
    Ozono, S
    Yamada, H
    Watanabe, H
    Ohashi, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P17 - P17
  • [25] Effect of the New Functional CYP3A4*22, CYP3A5 and ABCB1 Polymorphisms On the Tacrolimus Concentrations in Hispanic Kidney Transplant Recipients.
    Vu, D.
    Qwak, H.
    Sakharkar, P.
    Kim, J.
    Shah, T.
    Hutchinson, I.
    Naraghi, R.
    Min, D.
    TRANSPLANTATION, 2014, 98 : 888 - 889
  • [26] Effect of the New Functional CYP3A4*22, CYP3A5 and ABCB1 Polymorphisms On the Tacrolimus Concentrations in Hispanic Kidney Transplant Recipients.
    Vu, D.
    Qwak, H.
    Sakharkar, P.
    Kim, J.
    Shah, T.
    Hutchinson, I.
    Naraghi, R.
    Min, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 888 - 889
  • [27] THE EFFECT OF CYP3A4 AND CYP3A5 POLYMORPHISMS ON THE TACROLIMUS PLASMA CONCENTRATION IN CHINESE POST RENAL TRANSPLANT RECIPIENTS
    Wen, Gaiyan
    Yuan, Hong
    Xi, Lanyan
    Huang, Zhijun
    Li, Ying
    Lu, Yao
    JOURNAL OF HYPERTENSION, 2016, 34 : E300 - E300
  • [28] CYP3A4/5 polymorphisms affect the blood level of cyclosporine and tacrolimus in Chinese renal transplant recipients
    Li, Dan-ying
    Teng, Rui-chen
    Zhu, Huai-jun
    Fang, Yun
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (06) : 466 - 474
  • [29] ASSOCIATION OF CYP3A4*18B POLYMORPHISMS WITH THE PHARMACOKINETICS OF TACROLIMUS IN CHINESE RENAL TRANSPLANT RECIPIENTS
    Li Danying
    Fang Yun
    Teng Ruichen
    PROGRESS ON POST-GENOME TECHNOLOGIES AND MODERN NATURAL PRODUCTS, 2011, 2011, : 250 - 252
  • [30] Influence of CYP3A5 Polymorphisms On Tacrolimus Pharmacokinetics and Renal Function in Renal Transplant Recipients.
    Salvador-Garrido, P.
    Outeda-Macias, M.
    Pedreira-Vazquez, I.
    Elberdin-Pazos, L.
    Fernandez-Rivera, C.
    Alonso-Hernandez, A.
    Martin-Herranz, I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 618 - 618